ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 595,11
-0,49%
Dow Jones
40 211,72
0,53%
DAX
18 526,37
-0,40%
Brent Oil
83,605
-0,87%
Bitcoin
62 961,03
-2,92%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
04/05/202212h35Business WirePureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022NASDAQ:PRTCPureTech Health PLC
29/04/202212h05Business WirePureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New StudyNASDAQ:PRTCPureTech Health PLC
28/04/202205h49TipRanksLeerink Partners Reiterates Their Buy Rating on PureTech Health (PRTC)NASDAQ:PRTCPureTech Health PLC
26/04/202212h52Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRTCPureTech Health PLC
26/04/202212h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
26/04/202208h00Business WirePureTech Announces Annual Results for Year Ended December 31, 2021NASDAQ:PRTCPureTech Health PLC
13/04/202217h46Business WirePureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 ResultsNASDAQ:PRTCPureTech Health PLC
12/04/202213h05Business WirePureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant MedicationNASDAQ:PRTCPureTech Health PLC
12/04/202208h00Business WirePureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)NASDAQ:PRTCPureTech Health PLC
07/04/202208h00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
24/03/202208h00Business WirePureTech Appoints Sharon Barber-Lui to Board of Directors & Audit CommitteeNASDAQ:PRTCPureTech Health PLC
17/03/202214h05Business WirePureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product OfficerNASDAQ:PRTCPureTech Health PLC
16/03/202211h35Business WirePureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online TrafficNASDAQ:PRTCPureTech Health PLC
08/03/202213h05Business WirePureTech Founded Entity Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022NASDAQ:PRTCPureTech Health PLC
17/02/202213h05Business WirePureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional FunctioningNASDAQ:PRTCPureTech Health PLC
15/02/202208h00Business WirePureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. INASDAQ:PRTCPureTech Health PLC
10/02/202213h00Business WirePureTech to Present at the SVB Leerink 11th Annual Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
31/01/202212h50Business WirePureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting NormsNASDAQ:PRTCPureTech Health PLC
26/01/202213h02Business WirePureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. INASDAQ:PRTCPureTech Health PLC
14/01/202208h00Business WirePureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with CapstarNASDAQ:PRTCPureTech Health PLC
07/01/202213h30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), PureTech Health (PRTC)NASDAQ:PRTCPureTech Health PLC
07/01/202213h00Business WirePureTech to Present at 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
06/01/202208h00Business WirePureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to PirfenidoneNASDAQ:PRTCPureTech Health PLC
05/01/202213h05Business WirePureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit CommitteeNASDAQ:PRTCPureTech Health PLC
21/12/202111h55TipRanksLeerink Partners Thinks PureTech Health’s Stock is Going to RecoverNASDAQ:PRTCPureTech Health PLC
16/12/202108h00Business WirePureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded EntitiesNASDAQ:PRTCPureTech Health PLC
08/12/202113h00Business WirePureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
07/12/202113h00Business WirePureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological ConditionsNASDAQ:PRTCPureTech Health PLC
01/12/202113h10Business WirePureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition OfficerNASDAQ:PRTCPureTech Health PLC
18/11/202113h10Business WirePureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from RoNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

EU
DG
Vinci
EU
RNO
Renault
EU
EN
Bouygues
EU
ACA
Credit Agricole
NYSE
NKE
Nike
EU
CS
Axa
EU
BN
Danone
EU
ML
Michelin
EU
RI
Pernod Ricard
NASDAQ
NVDA
NVIDIA
EU
MC
Lvmh Moet Hennessy Louis...
EU
VIV
Vivendi
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
EU
LR
Legrand
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés